Physician

Andreas Karachristos, MD

According to 2025 Medicare claims, Andreas Karachristos, MD (NPI: 1154524098) practices surgical oncology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is TAMPA GENERAL MEDICAL GROUP INC (NPI: 1043557853; TIN: 274749421) and primary practice location at 33606-3571. Karachristos is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Karachristos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 145 traditional Medicare patients, billed 343 HCPCS/CPT codes, and received $96,220 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 12 prescription claims totaling $2,335 in drug costs. Open Payments data shows 7 records totaling $11,970. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $106,318 and ending at $96,220. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $33,729 to $2,335. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$62K$125K2015 Medicare payment: $106,318 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $97,676 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $124,544 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $123,566 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $32,503 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $56,751 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $62,296 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $70,957 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $79,625 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $96,220 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015152465$106,318
2016148413$97,676
2017152445$124,544
2018156368$123,566
20195492$32,503
202075142$56,751
202191161$62,296
2022112250$70,957
2023139338$79,625
2024145343$96,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$34K2015 Drug cost: $33,729 (USD; Tot_Drug_Cst)2016 Drug cost: $7,105 (USD; Tot_Drug_Cst)2017 Drug cost: $10,200 (USD; Tot_Drug_Cst)2018 Drug cost: $11,049 (USD; Tot_Drug_Cst)2019 Drug cost: $4,174 (USD; Tot_Drug_Cst)2021 Drug cost: $13,105 (USD; Tot_Drug_Cst)2022 Drug cost: $8,315 (USD; Tot_Drug_Cst)2023 Drug cost: $4,856 (USD; Tot_Drug_Cst)2024 Drug cost: $2,335 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201548111$33,729
20162545$7,105
20172550$10,200
20181849$11,049
2019N/R11$4,174
2020N/RN/RN/R
20211118$13,105
2022N/R12$8,315
2023N/R18$4,856
2024N/R12$2,335

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4949$112
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more90131$86

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$742HISTOSONICS,INC.
Research PaymentsReported research-related payment or transfer-of-value amount.2$11,228AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andreas Karachristos, MD?

Tedicare shows public-source Medicare data for Andreas Karachristos, MD (NPI 1154524098), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andreas Karachristos, MD have ACO affiliation data?

Andreas Karachristos, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Andreas Karachristos, MD?

Andreas Karachristos, MD is linked to TAMPA GENERAL MEDICAL GROUP INC (billing NPI 1043557853) in the available physician profile data.

Does Andreas Karachristos, MD have Open Payments data?

Andreas Karachristos, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.